Molecular Biomarkers for Predicting Cancer Patient Radiosensitivity and Radiotoxicity in Clinical Practice
Radiotherapy (RT) is a major part of cancer treatment. The reported variability in patient response to this modality can interfere with the continuation of best-possible care, promote side effects, and lead to long-term morbidity. Tools to predict a patient’s response to radiation could be highly us...
Main Authors: | Angeliki Gkikoudi, Spyridon A. Kalospyros, Sotiria Triantopoulou, Stella Logotheti, Vasiliki Softa, Constantin Kappas, Kiki Theodorou, Evagelia C. Laiakis, Gina Manda, Georgia I. Terzoudi, Alexandros G. Georgakilas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/13/23/12564 |
Similar Items
-
Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers
by: Vasiliki Zoi, et al.
Published: (2022-01-01) -
Radiosensitization: Studies and Modern Approaches to Cellular Radiosensitivity
by: Juan C. Alamilla-Presuel
Published: (2023-09-01) -
Radiosensitizers, radioprotectors, and radiation mitigators
by: Jayam Raviraj, et al.
Published: (2014-01-01) -
Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization
by: George Yang, et al.
Published: (2021-10-01) -
Human Radiosensitivity and Radiosusceptibility: What Are the Differences?
by: Laura El-Nachef, et al.
Published: (2021-07-01)